Action FLXN FLEXION THERAPEUTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Flexion Therapeutics, Inc.

Actions

FLXN

US33938J1060

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Renovacor Names New CFO
Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
North American Morning Briefing : Stock Futures -3-
FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, (form 8-K)
Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from NASDAQ Composite Index
Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from S&P Global BMI Index
Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from S&P TMI Index
Pacira BioSciences, Inc. completed the acquisition of Flexion Therapeutics, Inc..
Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from NASDAQ Biotechnology Index
FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
North American Morning Briefing : Stock Futures -3-
North American Morning Briefing : Stock Futures -3-
FLEXION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion Therapeutics, Inc. - FLXN
FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)
Flexion Therapeutics : Health Care Stocks Sliding in Late Monday Trading
Sector Update: Health Care
NASDAQ 100 : Top Midday Gainers
Protagonist Therapeutics : Health Care Stocks Trade Lower Premarket Monday
DJ Industrial : Wall Street Declines on Soaring Energy Prices
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action FLXN
  4. Actualités Flexion Therapeutics, Inc.
  5. Autres langues